SEGMENT INFORMATION

9 Months Ended

Jun. 30, 2014

SEGMENT INFORMATION [Abstract]

SEGMENT INFORMATION

6. SEGMENT INFORMATION

We operate in two principal segments - research services and research products. Our Services segment provides research and development support on a contract basis directly to pharmaceutical companies. Our Products segment provides liquid chromatography, electrochemical and physiological monitoring products to pharmaceutical companies, universities, government research centers and medical research institutions. Our accounting policies in these segments are the same as those described in the summary of significant accounting policies found in Note 2 to Consolidated Financial Statements in our annual report on Form 10-K for the year ended September 30, 2013.

	Three Months Ended June 30,						Nine Months Ended June 30,
	2014			2013			2014			2013
Revenue:
Service	$	4,754		$	4,156		$	14,196		$	12,493
Product		1,278			1,444			3,968			4,067
	$	6,032		$	5,600		$	18,164		$	16,560
Operating income (loss):
Service	$	293		$	222		$	669		$	71
Product		(37	)		216			154			661
	$	256		$	438		$	823		$	732
Interest expense		(123	)		(163	)		(408	)		(492	)
Change in fair value of warrant liability - decrease (increase)		66			318			(1,095	)		293
Other income		1			1			6			6
Income (loss) before income taxes	$	200		$	594		$	(674	)	$	539